Targeted therapeutic options based on the pathogenesis of IgA nephropathy
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-04-02 15:43:13 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
S Bo, A Sun, W Yang, X Wang…
Nephrology Dialysis …, 2026
academic.oup.com
… Immunoglobulin A nephropathy (IgAN) remains the leading … of sibeprelimab in a broader range of IgAN patients. In the … It is worth noting that this treatment regimen does not increase …

